Download:
pdf |
pdfCenters for Medicare & Medicaid Services
CMS eXpedited Life Cycle (XLC)
Medicaid and CHIP Program (MACPro)
AQM 2017 – Diabetes Screening for People with
Schizophrenia or Bipolar Disorder Who Are Using
Antipsychotic Medications (SSD) Core Measure
PRA document
Version 1.0
08/29/2017
Document Number: 290-QSSI-MACPro-PRA-AQM2017-SSD-D
Contract Number: HHSM-500-2007-00024I: HHSM-500-T0014
CMS XLC
Table of Contents
Table of Contents
1. (SSD) Core Measure – Screenshots ....................................................................... 1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
Are you reporting on this measure? ................................................................ 1
Measurement Specification – Path 1 ............................................................... 1
Measurement Specification – Path 2 ............................................................... 1
Data Source .................................................................................................... 2
Performance Measure ..................................................................................... 2
Deviations from Measurement Specifications ................................................. 2
Optional Measure Stratification ....................................................................... 2
Appendix A:
Acronyms ......................................................................................... 4
List of Figures
Figure 1: Are you reporting on this measure ................................................................... 1
Figure 2: Measurement Specification – 1 ........................................................................ 1
Figure 3: Measurement Specification – 2 ........................................................................ 1
Figure 4: Data Source ..................................................................................................... 2
Figure 5: Performance Measure ...................................................................................... 2
Figure 6: Deviations from Measurement Specifications .................................................. 2
Figure 7: Optional Measure Stratification – 1 .................................................................. 3
Figure 8: Optional Measure Stratification – 2 .................................................................. 3
List of Tables
Table 1: Acronyms .......................................................................................................... 4
AQM 2017 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Core
Measure PRA document
Version 1.0
i
08/29/2017
CMS XLC
(SSD) Core Measure – Screenshots
1. (SSD) Core Measure – Screenshots
1.1
Are you reporting on this measure?
Figure 1: Are you reporting on this measure?
1.2
Measurement Specification – Path 1
Figure 2: Measurement Specification – 1
1.3
Measurement Specification – Path 2
Figure 3: Measurement Specification – 2
AQM 2017 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Core
Measure PRA document
Version 1.0
1
08/29/2017
CMS XLC
(SSD) Core Measure – Screenshots
1.4
Data Source
Figure 4: Data Source
1.5
Performance Measure
Figure 5: Performance Measure
1.6
Deviations from Measurement Specifications
Figure 6: Deviations from Measurement Specifications
1.7
Optional Measure Stratification
Note: Same N/D/R sets are displayed under each of the stratification categories
AQM 2017 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Core
Measure PRA document
Version 1.0
2
08/29/2017
CMS XLC
(SSD) Core Measure – Screenshots
Figure 7: Optional Measure Stratification – 1
Figure 8: Optional Measure Stratification – 2
AQM 2017 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Core
Measure PRA document
Version 1.0
3
08/29/2017
CMS XLC
(SSD) Core Measure – Screenshots
Appendix A: Acronyms
Table 1: Acronyms
Acronym
Literal Translation
AQM
Adult Quality Measure
PRA
Paper Reduction Act of 1995
SDD
Diabetes Screening for People with Schizophrenia or Bipolar
Disorder Who Are Using Antipsychotic Medications
AQM 2017 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Core
Measure PRA document
Version 1.0
4
08/29/2017
File Type | application/pdf |
File Modified | 2017-09-08 |
File Created | 2017-09-08 |